カテゴリ： MarketLine, バミューダ, 企業調査

Lazard Ltd：企業の戦略・SWOT・財務分析

◆英語タイトル：Lazard Ltd - Strategy, SWOT and Corporate Finance Report
◆商品コード：SWOT20MY3541
◆発行会社（調査会社）：MarketLine
◆発行日：2019年12月
◆ページ数：48
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：バミューダ
◆産業分野：Financial Services
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Lazard Ltd – Strategy, SWOT and Corporate Finance Report
Summary

Lazard Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Lazard Ltd (Lazard) offers asset management and financial advisory services. Its asset management business comprises global investment solutions and investment management services. The company offers investments in mutual funds, closed-end funds and retirement plans through multi-asset, global equity, US equity, emerging markets, fixed income, real assets, and alternative investments. It offers financial advisory services on mergers and acquisitions, strategic matters, middle markets, restructuring, capital markets, capital structure, and private capital to corporate leaders and governments. Lazard also offers funding to high quality middle market companies. The company has presence in Europe, Asia, North America, the Middle East, Central and South America and Australia. Lazard is headquartered in Hamilton, Bermuda.

Scope

- Detailed information on Lazard Ltd required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Lazard Ltd in the form of a SWOT analysis
- An in-depth view of the business model of Lazard Ltd including a breakdown and examination of key business segments
- Intelligence on Lazard Ltd’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Lazard Ltd, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Lazard Ltd and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Lazard Ltd as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Lazard Ltd’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Lazard Ltd: Company Overview
Lazard Ltd: Overview and Key Facts
Lazard Ltd: Overview
Lazard Ltd: Key Facts
Lazard Ltd: Key Employees
Lazard Ltd: Key Employee Biographies
Lazard Ltd: Major Products and Services
Lazard Ltd: Company History
Lazard Ltd: Management Statement
Lazard Ltd: Locations and Subsidiaries
Lazard Ltd: Key Competitors
Lazard Ltd: Company Analysis
Lazard Ltd: Business Description
Lazard Ltd: SWOT Analysis
Lazard Ltd: SWOT Overview
Lazard Ltd: Strengths
Lazard Ltd: Weaknesses
Lazard Ltd: Opportunities
Lazard Ltd: Threats
Lazard Ltd: Corporate Financial Deals Activity
Lazard Ltd: Financial Deals Overview
Lazard Ltd: Targets and Partners
Lazard Ltd: Top Deals 2015 – 2019YTD*
Lazard Ltd: Mergers and Acquisitions
Lazard Ltd: Recent Developments
Lazard Ltd: News and Events Summary
Lazard Ltd: Business Expansion
Lazard Ltd: Contracts
Lazard Ltd: Corporate Governance
Lazard Ltd: Financial Performance
Lazard Ltd: Red Flags/DistressSignals
Lazard Ltd: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Lazard Ltd: Key Facts
Table 2: Lazard Ltd: Key Employees
Table 3: Lazard Ltd: Company History
Table 4: Lazard Ltd: Locations and Subsidiaries
Table 5: Lazard Ltd: Key Competitors
Table 6: Lazard Ltd: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 7: Lazard Ltd: Targets and Partners
Table 8: Lazard Ltd: Top Deals 2015 - 2019YTD*
Table 9: Lazard Ltd: M&A Volume and Value Trend (2015 - YTD*2019)
Table 10: Lazard Ltd: M&A Activity by Geography (2015 - YTD*2019)
Table 11: Lazard Ltd: News and Events Summary
Table 12: Lazard Ltd: Business Expansion
Table 13: Lazard Ltd: Contracts
Table 14: Lazard Ltd: Corporate Governance
Table 15: Lazard Ltd: Financial Performance
Table 16: Lazard Ltd: Red Flags/DistressSignals
Table 17: Lazard Ltd: Strategy and Operations

★海外企業調査レポート[Lazard Ltd：企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Michael J Fox Foundation for Parkinson’s Research：製薬・医療：M&Aディール及び事業提携情報
    Summary Michael J Fox Foundation for Parkinson's Research (Michael J. Fox) is a research foundation that conducts research on Parkinson's disease. The foundation offers research and development of therapies. It provides drug development and other research activities. Michael J. Fox offers treatments …
  • NOW Inc (DNOW)：企業の財務・戦略的SWOT分析
    NOW Inc (DNOW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Quantum Pharma Ltd：製薬・医療：M&Aディール及び事業提携情報
    Summary Quantum Pharma Ltd (Quantum Pharma), a subsidiary Clinigen Group Plc, is a manufacturer and supplier of unlicensed medicines. The company develops, manufactures, and supplies niche pharmaceutical products. It offers dermatology products, branded generics and vitamins, borderline substances, …
  • Meketa Investment Group：企業の戦略・SWOT・財務分析
    Meketa Investment Group - Strategy, SWOT and Corporate Finance Report Summary Meketa Investment Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Elekeiroz SA (ELEK3)：企業の財務・戦略的SWOT分析
    Elekeiroz SA (ELEK3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • New York Independent System Operator Inc：企業の戦略的SWOT分析
    New York Independent System Operator Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Enviva Partners LP (EVA)：企業の財務・戦略的SWOT分析
    Enviva Partners LP (EVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • UNeMed Corp：製薬・医療：M&Aディール及び事業提携情報
    Summary Unemed Corp (Unemed), a subsidiary of University of Nebraska Medical Center, is a healthcare service provider. The company offers services such as inventions, material transfer, confidentiality, intellectual property, startup formation and licensing process. Its technologies include therapeu …
  • Consumers Energy Company-エネルギー分野：企業M&A・提携分析
    Summary Consumers Energy Company (Consumers), formerly Consumers Power, is an electric and natural gas utility. The company generates purchases, transmits, distributes, and sells electricity. It also carries out the purchase, transmission, storage, distribution, and sale of natural gas. It generates …
  • Al Arrab Contracting Company：企業の戦略的SWOT分析
    Al Arrab Contracting Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Kaneka Corp (4118)：企業の財務・戦略的SWOT分析
    Kaneka Corp (4118) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • HokBen：企業の戦略・SWOT・財務分析
    HokBen - Strategy, SWOT and Corporate Finance Report Summary HokBen - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • OncoSil Medical Ltd (OSL)-医療機器分野：企業M&A・提携分析
    Summary OncoSil Medical Ltd (OncoSil), formerly NeuroDiscovery Ltd is a medical device company that develops and commercializes treatments for patients with pancreatic and liver cancer. The company’s lead product include oncosil, a brachytherapy device that emits beta radiation and is implanted dire …
  • G1 Therapeutics Inc (GTHX)：製薬・医療：M&Aディール及び事業提携情報
    Summary G1 Therapeutics Inc (G1 Therapeutics), formerly G Zero Therapeutics Inc, is a clinical stage biopharmaceutical company that discovers, develops and commercializes therapeutics for the treatment of cancer. The company’s pipeline products include trilaciclib (G1T28), a CDK4/6 inhibitor to pres …
  • The Norinchukin Bank：企業の戦略・SWOT・財務分析
    The Norinchukin Bank - Strategy, SWOT and Corporate Finance Report Summary The Norinchukin Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Singapore Technologies Aerospace Ltd.：企業の戦略・SWOT・財務情報
    Singapore Technologies Aerospace Ltd. - Strategy, SWOT and Corporate Finance Report Summary Singapore Technologies Aerospace Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Escalon Medical Corp (ESMC)：医療機器：M&Aディール及び事業提携情報
    Summary Escalon Medical Corp (Escalon) is a medical device company with primary focus on ophthalmology. It carries out the development and sale of ophthalmic medical devices. Its major products include A-Scan and B-Scan diagnostic tools, UBM high frequency/high resolution ultrasound devices, pachyme …
  • Rich Pharmaceuticals Inc (RCHA)：製薬・医療：M&Aディール及び事業提携情報
    Summary Rich Pharmaceuticals Inc (Rich Pharmaceuticals) is a biopharmaceutical company that offers discovery and development of therapies for the treatment of acute myelogenous leukemia (AML) in refractory patients. The company’s pipeline portfolio offers a lead drug candidate for the treatment of a …
  • Pentair plc：企業の戦略・SWOT・財務情報
    Pentair plc - Strategy, SWOT and Corporate Finance Report Summary Pentair plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Mega Financial Holding Co., Ltd.：戦略・SWOT・企業財務分析
    Mega Financial Holding Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Mega Financial Holding Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆